1. Health Canada: potential risk with unauthorised cell therapies

   News item 01 June 2019 Pages: 1 - 1

2. Hepatotoxicity with tocilizumab: Canadian and NZ warnings

   News item 01 June 2019 Pages: 2 - 2

3. Magnesium sulfate: neonatal skeletal AEs with in utero exposure

   News item 01 June 2019 Pages: 3 - 3

4. MHRA seeks help in reversing decline in Yellow Card reports

   News item 01 June 2019 Pages: 4 - 4

5. PMDA warning of serious lung disease with Verzenio

   Correspondence 01 June 2019 Pages: 5 - 5

6. PRAC recommends withdrawing MAAs for fenspiride in EU

   News item 01 June 2019 Pages: 6 - 6

7. Tofacitinib restrictions in place while EU review underway

   News item 01 June 2019 Pages: 7 - 7

8. US FDA warns of unauthorised devices for diabetes control

   News item 01 June 2019 Pages: 8 - 8

9. Infections with bDMARDs and glucocorticoids before arthroplasty

   Clinical study 01 June 2019 Pages: 9 - 9

10. Opioid-related fatal overdoses vary with naloxone access laws

    Clinical study 01 June 2019 Pages: 10 - 10

11. Opportunistic infections with ibrutinib

    Clinical study 01 June 2019 Pages: 11 - 11

12. Abemaciclib

    Case report 01 June 2019 Pages: 12 - 12

13. Adalimumab

    Case report 01 June 2019 Pages: 13 - 13

14. Adalimumab

    Case report 01 June 2019 Pages: 14 - 14

15. Adalimumab

    Case report 01 June 2019 Pages: 15 - 15

16. Adalimumab

    Case report 01 June 2019 Pages: 16 - 16

17. Alectinib

    Case report 01 June 2019 Pages: 17 - 17

18. Alemtuzumab

    Case report 01 June 2019 Pages: 18 - 18

19. Aloin/atropine/cathine/diazepam/liothyronine

    Case report 01 June 2019 Pages: 19 - 19

20. Alprazolam/paroxetine

    Case report 01 June 2019 Pages: 20 - 20

21. Alteplase

    Case report 01 June 2019 Pages: 21 - 21

22. Amiodarone

    Case report 01 June 2019 Pages: 22 - 22

23. Amlodipine/benazepril overdose

    Case report 01 June 2019 Pages: 23 - 23

24. Amoxicillin/clavulanic acid/digoxin/warfarin interaction

    Case report 01 June 2019 Pages: 24 - 24

25. Amphotericin-B/ethambutol/pyrazinamide

    Case report 01 June 2019 Pages: 25 - 25

26. Anthracyclines/trastuzumab

    Case report 01 June 2019 Pages: 26 - 26

27. Anti-digoxin polyclonal antibody/digoxin

    Case report 01 June 2019 Pages: 27 - 27

28. Anti-TB drugs

    Case report 01 June 2019 Pages: 28 - 28

29. Anticoagulants/antiplatelets

    Case report 01 June 2019 Pages: 29 - 29

30. Antiepileptics

    Case report 01 June 2019 Pages: 30 - 30

31. Antihypertensives/rifampicin interaction

    Case report 01 June 2019 Pages: 31 - 31

32. Antineoplastics

    Case report 01 June 2019 Pages: 32 - 32

33. Antineoplastics

    Case report 01 June 2019 Pages: 33 - 33

34. Antineoplastics

    Case report 01 June 2019 Pages: 34 - 34

35. Antineoplastics

    Case report 01 June 2019 Pages: 35 - 35

36. Antineoplastics

    Case report 01 June 2019 Pages: 36 - 36

37. Antineoplastics

    Case report 01 June 2019 Pages: 37 - 37

38. Antineoplastics

    Case report 01 June 2019 Pages: 38 - 38

39. Antineoplastics

    Case report 01 June 2019 Pages: 39 - 39

40. Antineoplastics

    Case report 01 June 2019 Pages: 40 - 40

41. Antineoplastics/folinic acid

    Case report 01 June 2019 Pages: 41 - 41

42. Antineoplastics/loxoprofen

    Case report 01 June 2019 Pages: 42 - 42

43. Antiretrovirals

    Case report 01 June 2019 Pages: 43 - 43

44. Antivirals

    Case report 01 June 2019 Pages: 44 - 44

45. Aripiprazole/penicillamine

    Case report 01 June 2019 Pages: 45 - 45

46. Aspirin

    Case report 01 June 2019 Pages: 46 - 46

47. Aspirin

    Case report 01 June 2019 Pages: 47 - 47

48. Aspirin overdose

    Case report 01 June 2019 Pages: 48 - 48

49. Aspirin/heparin/prasugrel

    Case report 01 June 2019 Pages: 49 - 49

50. Atezolizumab

    Case report 01 June 2019 Pages: 50 - 50